vs
Side-by-side financial comparison of Hamilton Lane INC (HLNE) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $198.6M, roughly 1.0× Hamilton Lane INC). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 29.4%, a 28.0% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $72.4M).
Hamilton Lane Incorporated is an American alternative investment management and advisory company headquartered in Conshohocken, Pennsylvania. The company provides private markets investments to its clients.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
HLNE vs IDYA — Head-to-Head
Income Statement — Q3 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $198.6M | $207.8M |
| Net Profit | $58.4M | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 60.5% | 52.2% |
| Net Margin | 29.4% | 57.4% |
| Revenue YoY | 18.0% | — |
| Net Profit YoY | 10.2% | 330.1% |
| EPS (diluted) | — | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $198.6M | — | ||
| Q3 25 | $190.9M | $207.8M | ||
| Q2 25 | $176.0M | — | ||
| Q1 25 | $198.0M | — | ||
| Q4 24 | $168.3M | — | ||
| Q3 24 | $150.0M | $0 | ||
| Q2 24 | $196.7M | $0 | ||
| Q1 24 | $176.7M | $0 |
| Q4 25 | $58.4M | — | ||
| Q3 25 | $70.9M | $119.2M | ||
| Q2 25 | $53.7M | — | ||
| Q1 25 | $50.5M | — | ||
| Q4 24 | $53.0M | — | ||
| Q3 24 | $55.0M | $-51.8M | ||
| Q2 24 | $59.0M | $-52.8M | ||
| Q1 24 | $48.4M | $-39.6M |
| Q4 25 | 60.5% | — | ||
| Q3 25 | 61.6% | 52.2% | ||
| Q2 25 | 54.2% | — | ||
| Q1 25 | 44.6% | — | ||
| Q4 24 | 53.6% | — | ||
| Q3 24 | 51.4% | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | 55.0% | — |
| Q4 25 | 29.4% | — | ||
| Q3 25 | 37.1% | 57.4% | ||
| Q2 25 | 30.5% | — | ||
| Q1 25 | 25.5% | — | ||
| Q4 24 | 31.5% | — | ||
| Q3 24 | 36.7% | — | ||
| Q2 24 | 30.0% | — | ||
| Q1 24 | 27.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $1.33 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.60 | ||
| Q2 24 | — | $-0.68 | ||
| Q1 24 | — | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $786.9M |
| Total DebtLower is stronger | $279.5M | — |
| Stockholders' EquityBook value | $877.4M | $1.1B |
| Total Assets | $2.2B | $1.2B |
| Debt / EquityLower = less leverage | 0.32× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $786.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $920.0M | ||
| Q2 24 | — | $701.7M | ||
| Q1 24 | — | $698.8M |
| Q4 25 | $279.5M | — | ||
| Q3 25 | $285.6M | — | ||
| Q2 25 | $288.6M | — | ||
| Q1 25 | $290.3M | — | ||
| Q4 24 | $292.0M | — | ||
| Q3 24 | $195.0M | — | ||
| Q2 24 | $195.6M | — | ||
| Q1 24 | $196.2M | — |
| Q4 25 | $877.4M | — | ||
| Q3 25 | $825.8M | $1.1B | ||
| Q2 25 | $758.8M | — | ||
| Q1 25 | $717.3M | — | ||
| Q4 24 | $649.3M | — | ||
| Q3 24 | $606.6M | $1.2B | ||
| Q2 24 | $566.4M | $931.7M | ||
| Q1 24 | $525.2M | $935.3M |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.0B | $1.2B | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.4B | $1.2B | ||
| Q2 24 | $1.4B | $973.7M | ||
| Q1 24 | $1.3B | $961.5M |
| Q4 25 | 0.32× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.38× | — | ||
| Q1 25 | 0.40× | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.37× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.1M | $142.2M |
| Free Cash FlowOCF − Capex | $72.4M | $142.2M |
| FCF MarginFCF / Revenue | 36.5% | 68.4% |
| Capex IntensityCapex / Revenue | 0.8% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.27× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $606.5M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.1M | — | ||
| Q3 25 | $118.9M | $142.2M | ||
| Q2 25 | $128.9M | — | ||
| Q1 25 | $300.8M | — | ||
| Q4 24 | $64.4M | — | ||
| Q3 24 | $117.4M | $-49.2M | ||
| Q2 24 | $79.7M | $-32.9M | ||
| Q1 24 | $120.9M | $-43.8M |
| Q4 25 | $72.4M | — | ||
| Q3 25 | $117.8M | $142.2M | ||
| Q2 25 | $127.6M | — | ||
| Q1 25 | $288.7M | — | ||
| Q4 24 | $58.8M | — | ||
| Q3 24 | $115.8M | $-49.7M | ||
| Q2 24 | $78.2M | $-33.9M | ||
| Q1 24 | $109.8M | $-45.1M |
| Q4 25 | 36.5% | — | ||
| Q3 25 | 61.7% | 68.4% | ||
| Q2 25 | 72.5% | — | ||
| Q1 25 | 145.8% | — | ||
| Q4 24 | 34.9% | — | ||
| Q3 24 | 77.2% | — | ||
| Q2 24 | 39.8% | — | ||
| Q1 24 | 62.1% | — |
| Q4 25 | 0.8% | — | ||
| Q3 25 | 0.6% | 0.0% | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 6.3% | — |
| Q4 25 | 1.27× | — | ||
| Q3 25 | 1.68× | 1.19× | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 5.96× | — | ||
| Q4 24 | 1.22× | — | ||
| Q3 24 | 2.14× | — | ||
| Q2 24 | 1.35× | — | ||
| Q1 24 | 2.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HLNE
| Management And Advisory Fee Revenue Specialized Funds | $98.5M | 50% |
| Incentive Fee Revenue Specialized Funds | $39.4M | 20% |
| Management And Advisory Fee Revenue Customized Separate Accounts | $36.1M | 18% |
| Management And Advisory Fee Revenue Reporting And Other | $9.3M | 5% |
| Incentive Fee Revenue Customized Separate Accounts | $5.9M | 3% |
| Management And Advisory Fee Revenue Advisory | $4.8M | 2% |
| Management And Advisory Fee Revenue Fund Reimbursement Revenue | $3.9M | 2% |
IDYA
Segment breakdown not available.
